Compare IOSP & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOSP | PRGO |
|---|---|---|
| Founded | 1938 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 1998 | 2013 |
| Metric | IOSP | PRGO |
|---|---|---|
| Price | $100.14 | $15.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $101.00 | $16.50 |
| AVG Volume (30 Days) | 189.7K | ★ 2.3M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | 1.81% | ★ 7.30% |
| EPS Growth | ★ 228.87 | N/A |
| EPS | ★ 2.47 | N/A |
| Revenue | ★ $1,778,000,000.00 | $800,000.00 |
| Revenue This Year | $7.14 | N/A |
| Revenue Next Year | $5.81 | $0.73 |
| P/E Ratio | $41.08 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $65.51 | $9.23 |
| 52 Week High | $101.80 | $20.65 |
| Indicator | IOSP | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 61.16 | 54.71 |
| Support Level | $91.70 | $13.55 |
| Resistance Level | N/A | $16.79 |
| Average True Range (ATR) | 1.74 | 0.59 |
| MACD | 0.16 | -0.08 |
| Stochastic Oscillator | 70.49 | 37.05 |
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.